Filter
614
Text search:
FDA
Featured
Recommendations
81
New Publications
121
Language
Document type
No document type
303
Guidelines
160
Studies & Reports
75
Manuals
24
Fact sheets
24
Strategic & Response Plan
13
Training Material
7
Resource Platforms
3
Brochures
2
Situation Updates
2
Infographics
1
Countries / Regions
India
29
Ghana
17
Latin America and the Carribbean
17
Russia
17
Philippines
12
Myanmar / Burma
12
South Africa
9
Middle East and North Africa
9
USA
8
Kenya
8
Brazil
8
Global
8
Nigeria
7
Congo, Democratic Republic of
7
Germany
7
Syria
7
Argentina
7
West and Central Africa
7
Senegal
6
Uganda
6
Ukraine
6
Colombia
6
Ecuador
6
Yemen
6
Western and Central Europe
6
South Sudan
5
Angola
5
Paraguay
5
Eastern Europe
5
Burkina Faso
4
Liberia
4
Mali
4
Ethiopia
4
Indonesia
4
Mozambique
4
Sudan
4
Peru
4
Eastern Europe and Central Asia
4
Guinea
3
Sierra Leone
3
Nepal
3
Tanzania
3
Thailand
3
Bangladesh
3
Bolivia
3
East and Southern Africa
3
South–East Asia Region
3
Africa
3
Venezuela
3
France
3
Guinea-Bissau
2
Côte d’Ivoire / Ivory Coast
2
Niger
2
Haiti
2
Iraq
2
Jordan
2
Rwanda
2
Namibia
2
El Salvador
2
Chile
2
Asia
2
Albania
2
Tajikistan
2
Morocco
1
Saudi Arabia
1
Cameroon
1
Zimbabwe
1
Somalia
1
Lebanon
1
Egypt
1
Chad
1
Cambodia
1
Mauritania
1
Singapore
1
Malawi
1
Benin
1
Dominican Republic
1
Cuba
1
Honduras
1
Botswana
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Armenia
1
Congo-Brazzaville
1
Qatar
1
Moldova
1
Kazakhstan
1
Tunisia
1
Spain
1
Belarus
1
Israel
1
Authors & Publishers
Publication Years
Category
Countries
190
Clinical Guidelines
80
Pharmacy & Technologies
22
Women & Child Health
17
Public Health
11
Key Resources
8
Capacity Building
2
Toolboxes
COVID-19
136
Mental Health
69
TB
59
HIV
48
Pharmacy
35
AMR
30
Ebola
28
Rapid Response
17
Specific Hazards
13
NTDs
10
Zika
8
Refugee
7
NCDs
7
Planetary Health
6
Cholera
3
Conflict
3
Natural Hazards
3
Caregiver
3
Global Health Education
2
Disability
1
During fresh fruit and vegetables (FFV) production, water is used for a variety of purposes. Even the water was conventionally treated and disinfected, it may still potentially contain human pathogens, albeit at low concentrations. A risk assessment, appropriate to the national or local production c
...
Antibiotics 2022, 11(3), 329; https://doi.org/10.3390/antibiotics11030329.
The authors found that the most-represented antibiotics on the Rwandan market were amoxicillin, co-trimoxazole and cloxacillin. No counterfeit antibiotics were found in this study. However, substandard batches with moderate
...
A view of global supply chains, pressure points, and implications for antimicrobial resistance response
2016 ASCO EDUCATIONAL BOOK | asco.org/edbo
Environmental pollution, protection, quality and sustainability
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently,
...
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed
to support decision making. A countrywide mass vaccination campaign with the
use of an inactivated severe acute respiratory syndrome c
...
El documento “Preguntas y respuestas sobre la tuberculosis” provee
información sobre el diagnóstico y el tratamiento de la infección de
tuberculosis y de la enfermedad de tuberculosis. Las audiencias principales
para este material informativo son las personas con TB o en riesgo de
contrae
...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f
...
Clinical features and management of human monkeypox: a retrospective observational study in the UK
recommended
Cases of human monkeypox are rarely seen outside of west and central Africa. There are few data regarding viral kinetics or the duration of viral shedding and no licensed treatments. Two oral drugs, brincidofovir and tecovirimat, have been approved for treatment of smallpox and have demonstrated eff
...
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact
...
The goal of the global outbreak response for monkeypox is to stop human-to-human transmission of monkeypox, with a priority focus on communities at high risk of exposure which may differ according to context, and to effectively use strong public health measures to prevent onward spread of the diseas
...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons
...
Updated recommendations on treatment of adolescents and children with chronic HCV infection
recommended
The new treatment recommendations that extend the 2018 treat all recommendation for adults with chronic HCV infection to include adolescents and children down to 3 years, and to align the existing recommended pangenotypic direct-acting antiviral (DAA) regimens (SOF/DCV, SOF/VEL and G/P) for adults,
...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent
...
This document aims to provide interim guidance for microbiology and virology experts, other laboratory professionals, laboratory managers, infectious disease programme managers, public health professionals and other stakeholders that provide primary, confirmatory or advanced testing for SARS-CoV-2,
...
